Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News New NoriZite™ Nasal Spray launches in the UK Award-winning innovation from Birmingham Biotech Ltd and University of Birmingham is now available in the UK
11 May 2021 Agents that target viral RNA could be the basis for next generation broad spectrum anti-viral drugs Latest research has found a new approach to tackling viruses by targeting the 'control centre' in viral RNA, leading to broad spectrum anti-viral drugs.
06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration to accelerate drug discovery projects that will fast track research from lab to patient.
05 May 2021 Successful virtual conference for global bacterial vaccinology network Over 200 scientists and industry figures worldwide gathered online for the BactiVac Virtual Network Conference 2021 hosted at the University of Birmingham.
21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
14 April 2021 Over-80s show similar antibody responses following either one Pfizer or AstraZeneca vaccine Latest study finds over-80's receiving a dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
01 April 2021 Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people A University of Birmingham-led study has found that 98% of over-80's who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.
29 March 2021 New study finds strong immune response following COVID-19 vaccination University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.